Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05226078 · ClinicalTrials.gov registry record · NA
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients
A NA study of Chronic Insomnia and Cancer-related Problem/Condition, sponsored by Abramson Cancer Center at Penn Medicine.
- Active
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT05226078 is a NA study of Chronic Insomnia and Cancer-related Problem/Condition that is active but no longer recruiting, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 64 participants, below the 25,393-participant average among 11 other Chronic Insomnia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05226078, a NA study of Chronic Insomnia and Cancer-related Problem/Condition, is active but no longer recruiting, sponsored by Abramson Cancer Center at Penn Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
Cancer-related fatigue (CRF) and insomnia are prevalent among cancer patients and have been linked to de-creases in quality of life and poorer overall survivorship. Currently, the mechanisms underlying CRF are not well understood, which has led to treatments that are only moderately effective. In addition, when compared to CBT-I in the general population, the treatment outcomes in CBT-I with cancer patients are subpar and, as such, this study will evaluate whether dose of CBT-I is effective in ameliorating CRF.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy for Insomnia
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05226078
The ClinicalTrials.gov registry entry for NCT05226078 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 25,393-participant average among 11 other Chronic Insomnia trials with a reported enrollment target (100% lower). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Chronic Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy for Insomnia is the first listed.
NCT05226078 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05226078 about?
NCT05226078 is a clinical study titled "The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients". Cancer-related fatigue (CRF) and insomnia are prevalent among cancer patients and have been linked to de-creases in quality of life and poorer overall survivorship. Currently, the mechanisms underlying CRF are not well understood, which has led to treatments that are only moderately effective. In ad...
What is the current status of trial NCT05226078?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2023-03-01. Estimated completion is 2026-11-30.
What conditions does trial NCT05226078 study?
This clinical trial studies the following conditions: Chronic Insomnia, Cancer-related Problem/Condition, Cancer-Related Syndrome.
What interventions are being tested in trial NCT05226078?
The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT05226078?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05226078 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Sleep and Reducing Opioid Use in Individuals With Chronic Pain
RECRUITING · NA
-
Insomnia Behavioral Intervention Study
RECRUITING · NA
-
Comparing Insomnia Care As Usual to Digital Augmentation (CICADA)
RECRUITING · NA
-
Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study
COMPLETED · NA
-
Naturalistic Monitoring and Treatment of Chronic Insomnia
COMPLETED · NA
-
Brief Behavioral Treatment for Insomnia in Cancer Survivors
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.